Antisense modulation of kinesin-like 1 expression

Details Antisense modulation of kinesin-like 1 expression Antisense modulation of kinesin-like 1 expression

2007-04-03

2007-04-03

McGarry, Sean (Department: 1635)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024100, C536S024500, C435S006120, C435S375000, C435S477000

Reexamination Certificate

active

10714796

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of kinesin-like 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding kinesin-like 1. Methods of using these compounds for modulation of kinesin-like 1 expression and for treatment of diseases associated with expression of kinesin-like 1 are provided.

REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 6468796 (2002-10-01), Watt
patent: 6472521 (2002-10-01), Uhlmann et al.
patent: 2002/0165240 (2002-11-01), Kimball et al.
patent: 2004/0009156 (2004-01-01), Reinhard et al.
patent: WO 03/030832 (2003-04-01), None
Blangy, et al., “Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo,”Cell, 1995, 83, 1159-1169.
Ferhat, et al., “Expression of the mitotic motor protein Eg5 in postmitotic neurons: implications for neuronal development,”J. Neurosci., 1998, 18, 7822-7835.
Hansen, et al., “Activation of hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia,”Oncogene, 1999, 18, 6531-6539.
Kaiser, et al., “All-trans-retinoic acid-mediated growth inhibition involves inhibition of human kinesin-related protein HsEg5,”J. Biol. Chem., 1999, 274, 18925-18931.
Kapoor, et al., “Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5,”J. Cell Biol., 2000, 150, 975-988.
Mayer, et al., “Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen,”Science, 1999, 286, 971-974.
Miki, et al., “All kinesin superfamily protein, KIF, genes in mouse and human,”Proc. Natl. Acad. Sci. USA, 2001, 98, 7004-7011.
Whitehead, et al., “Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle,”J. Cell Sci., 1998, 111, 2551-2561.
Whitehead, et al., “The spindle kinesin-like protein HsEg5 is an autoantigen in systemic lupus erythematosus,”Arthritis Rheum., 1996, 39, 1635-1642.
Weil, D., et al., “Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells,” Short Technical Reports,BioTechniques, 2002, 33(6), 1244-1248.
Agrawal S., et al., “Antisense therapeutics: is it as simple as complementary base recognition? ”Molecular Med. Today, 2000, 6, 72-81.
Branch, A.D., “A good antisense molecule is hard to find,”TIBS, 1998, 23, 45-50.
Jen, K.-Y., et al., “Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies,”Stem Cells, 2000, 18, 307-319.

Affiliated with

Also associated with

Rating

Antisense modulation of kinesin-like 1 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of kinesin-like 1 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of kinesin-like 1 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3738946